Intervention Protocol

Angiotensin converting enzyme inhibitor induced angioedema in patients with primary hypertension

  1. Angeni Bheekie1,*,
  2. Kenechukwu Obikeze2,
  3. Ronald Nicolson3

Editorial Group: Cochrane Hypertension Group

Published Online: 8 OCT 2008

DOI: 10.1002/14651858.CD007437

How to Cite

Bheekie A, Obikeze K, Nicolson R. Angiotensin converting enzyme inhibitor induced angioedema in patients with primary hypertension (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD007437. DOI: 10.1002/14651858.CD007437.

Author Information

  1. 1

    University of Western Cape, School of Pharmacy, Bellville , South Africa

  2. 2

    University of the Western Cape, School of Pharmacy, Cape Town, South Africa

  3. 3

    Vanguard Community health Centre, Pharmacy, Cape Town, South Africa

*Angeni Bheekie, School of Pharmacy, University of Western Cape, P/Bag X17, Bellville , 7535 , South Africa. abheekie@uwc.ac.za.

Publication History

  1. Publication Status: New
  2. Published Online: 8 OCT 2008

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the incidence of angioedema associated with ACE inhibitors versus placebo in the treatment of primary hypertension.